You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Commave Therap Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for COMMAVE THERAP, and when can generic versions of COMMAVE THERAP drugs launch?

COMMAVE THERAP has one approved drug.

There are six US patents protecting COMMAVE THERAP drugs.

There are seventy patent family members on COMMAVE THERAP drugs in twenty-nine countries.

Summary for Commave Therap

International Patents:	70
US Patents:	6
Tradenames:	1
Ingredients:	1
NDAs:	1

Drugs and US Patents for Commave Therap

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Commave Therap	AZSTARYS	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	CAPSULE;ORAL	212994-002	May 7, 2021		RX	Yes	No	10,584,112	⤷ Sign Up	Y	Y		⤷ Sign Up
Commave Therap	AZSTARYS	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	CAPSULE;ORAL	212994-002	May 7, 2021		RX	Yes	No	10,954,213	⤷ Sign Up				⤷ Sign Up
Commave Therap	AZSTARYS	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	CAPSULE;ORAL	212994-001	May 7, 2021		RX	Yes	No	10,759,778	⤷ Sign Up	Y			⤷ Sign Up
Commave Therap	AZSTARYS	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	CAPSULE;ORAL	212994-002	May 7, 2021		RX	Yes	No	10,858,341	⤷ Sign Up				⤷ Sign Up
Commave Therap	AZSTARYS	dexmethylphenidate hydrochloride; serdexmethylphenidate chloride	CAPSULE;ORAL	212994-001	May 7, 2021		RX	Yes	No	10,954,213	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

International Patents for Commave Therap Drugs

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration
Israel	269322	⤷ Sign Up
South Korea	101869885	⤷ Sign Up
Denmark	3551619	⤷ Sign Up
Slovenia	2736510	⤷ Sign Up
Colombia	6900135	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Commave Therap

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.